Neuraxis, Inc. Form 8-K Summary
Business Context and Reporting Period
Neuraxis, Inc. (NRXS), a Delaware corporation listed on NYSE American, filed this Current Report on Form 8-K on August 29, 2025. The filing reports the entry into a material definitive agreement to raise capital through an "At The Market" (ATM) equity offering.
Key Financial Metrics and Transaction Details
This filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. The primary financial data relates to the new financing arrangement:
- Offering Size: Up to $3,300,000 in aggregate offering price of common stock.
- Sales Agent: Craig-Hallum Capital Group LLC.
- Commission: 3% of gross sales proceeds.
- Legal Expenses: Reimbursement up to $50,000 for the Sales Agent's legal counsel, plus up to $5,000 per due diligence update session.
- Registration Basis: Sales will be made under an effective Form S-3 (File No. 333-283798) declared effective on February 11, 2025.
Material Changes
The material change reported is the execution of the At The Market Offering Agreement on August 29, 2025. This agreement grants the Company the discretion to sell shares from time to time based on market conditions, subject to price, time, or size limits imposed by the Company.
Outlook, Risks, and Management Commentary
The filing indicates the Company intends to use this facility to raise capital as needed. The agreement includes customary indemnification rights for the Sales Agent. The filing explicitly states it does not constitute an offer to sell securities in any state where such an offer would be unlawful prior to registration. No specific guidance on future revenue or operational outlook is provided in this document.
Key Facts for Investor Verification
- Verify the current share price and float to assess the potential dilution impact of a $3.3 million offering.
- Confirm the status of the underlying Form S-3 registration statement (File No. 333-283798) to ensure it remains effective.
- Review the full text of the At The Market Offering Agreement (Exhibit 1.1) for specific termination clauses or conditions.
- Monitor future filings for actual sales activity and proceeds generated under this agreement.